Stock Quote
Alcon Inc (ACL.N) (New York Stock Exchange)
sector: Healthcare .
industry: Medical Equipment, Supplies & Distribution ยท
View ACL on other exchanges
$158.10
4:00pm EST
+5.57%
$149.76
$149.74
956,700
$160.49
$149.65
$149.97
$76.03
1.10
405,256
ACL.N
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Rayment, Cary | Non-Executive Chairman of the Board | 4,825,650 |
| Buehler, Kevin | Chief Executive Officer, President, Director | 1,464,380 |
| Castaner, Francisco | Vice Chairman of the Board | -- |
Profile
Alcon, Inc. (Alcon) is a research and development driven, global medical specialty company focused on eye care. The Company develops, manufactures and markets pharmaceuticals, surgical equipment and devices and consumer eye care products to treat diseases and disorders of the eye. Alcon manages its... Full Description
Company Address
Alcon Inc
Boesch 69
Huenenberg 6331
P: +4141.7858888
Boesch 69
Huenenberg 6331
P: +4141.7858888
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Allergan, Inc. | $58.62 | -0.28 |
| Pfizer Inc. | $18.74 | -0.11 |
| Merck & Co., Inc. | $36.80 | -0.08 |
| ACL.N | Industry | |
|---|---|---|
| P/E(TTM) | 22.84 | 3.85 |
| P/S(TTM) | 7.12 | 0.52 |
| ROI(TTM) | 35.20 | 2.79 |
| ROE(TTM) | 40.24 | 4.44 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 1.75 |
| EPS Est. (Current Year) | 6.66 |
| Total Revenue | $1,614.00M |
| Net Income | $515.00M |
| EPS | $1.71 |
